COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica dévoile son futur siège social à Paris
17/09/2024
EssilorLuxottica dévoile son futur siège social à Paris Paris, France (17septembre 2024) – EssilorLuxottica annonce la signature d'un bail de long-terme pour l’installation de son nouveau siège mondial à Paris, à [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
17/09/2024
Déclaration de transactions sur actions propres Paris, France (17 septembre 2024, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 10 septembre [...]
Idorsia continues to further the science of sleep and insomnia with new daridorexant data and analyses published at Sleep Europe 2024
17/09/2024
Allschwil, Switzerland – September 17, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data and analyses of daridorexant, Idorsia’s dual orexin receptor antagonist for the treatment of adults with chronic insomnia [...]
Stryker completes acquisition of care.ai
17/09/2024
Portage, Michigan, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in delivering AI-assisted [...]
Crossject to report first-half 2024 financial results and host webcast on September 23, 2024
17/09/2024
Dijon, France, 17 September, 2024 - Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing medicines for emergency situations harnessing its award-winning needle-free auto-injector ZENEO [...]
Crossject publiera ses résultats financiers du premier semestre et organisera un webcast le 23 Septembre 2024
17/09/2024
Dijon, France, 17 septembre 2024 - Crossject (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée dans le développement de médicaments pour les situations d'urgence exploitant son auto-injecteur [...]
Impact BioMedical Inc. Announces the Closing of its Initial Public Offering
17/09/2024
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced the closing of its [...]
Le seul vaccin contre le choléra à dose unique au Canada est disponible dans tout le pays
17/09/2024
TORONTO, 17 sept. 2024 (GLOBE NEWSWIRE) -- Bavarian Nordic, l’un des principaux fournisseurs mondiaux de vaccins pour voyageurs, a annoncé aujourd’hui la disponibilité commerciale de VAXCHORA ® , le seul vaccin oral à [...]
LifeLabs Celebrates Seventh Consecutive Win as the Only Canadian Company and Sole Laboratory in North America Recognized by Practice Greenhealth
17/09/2024
Toronto Ontario, Sept. 17, 2024 (GLOBE NEWSWIRE) -- LifeLabs, the leading medical laboratory in Canada, is proud to announce that it has received the Practice Greenhealth Partner for Change Award for the seventh [...]
ADIA Nutrition Stakes Claim in $6.7B Industry with Strategic Trademark Expansion
17/09/2024
WINTER PARK, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition Inc. (OTC Pink: ADIA) has announced the hiring of a prominent Winter Springs law firm to fortify its intellectual property holdings, specifically for [...]
Blackwell Captive Solutions and WellRithms Collaborative Partnership Helps Self-Insured Companies Mitigate Risk, Reduce Financial Burdens of High-Cost Medical Claims
17/09/2024
CHICAGO and PORTLAND, Ore., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Blackwell Captive Solutions , a leading provider of innovative captive solutions and WellRithms , the industry leading payment integrity firm, today [...]
Humber River Health ranks among top Ontario hospitals in National Surgical Quality Improvement Program
17/09/2024
TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Humber River Health (Humber) is pleased to have ranked among the top five Ontario hospitals for every category of the American College of Surgeons’ (ACS) 2023 National [...]
Tiny Health Appoints Dr. Elisa Song as Chief Medical Officer and Dr. Taylor Sittler as Board Director
17/09/2024
Gut Health innovator strengthens practitioner-focused strategy with industry leaders in precision medicine AUSTIN, Texas, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Tiny Health , a pioneer in at-home microbiome testing for [...]
Stonebriar Facial and Oral Surgery to Open McKinney Location Sept. 27
17/09/2024
MCKINNEY, Texas and FRISCO, Texas, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stonebriar Facial and Oral Surgery , an oral and maxillofacial surgery (OMS) practice in Frisco, Texas, will open a new location in McKinney at 2164 [...]
Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
17/09/2024
-Capricor to Receive $15 Million Equity Investment at a 20% Premium, as well as $20 Million Upfront Payment upon Signing Definitive Agreement with up to $715 Million in Potential Milestones and a Double-Digit Percentage [...]
CSL Joins Accumulus Synergy to Drive Industry Change
17/09/2024
Following the launch of Accumulus Synergy’s innovative cloud-based information exchange platform, CSL joins the nonprofit industry association BURLINGAME, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, [...]
CSL rejoint Accumulus Synergy pour faire évoluer le secteur
17/09/2024
Suite au lancement de la plateforme innovante d’échange d’informations basée sur le cloud d’Accumulus Synergy, CSL rejoint l’association industrielle à but non lucratif BURLINGAME, Californie, 17 sept. 2024 (GLOBE [...]
QHSLab Announces Major Research and Development Milestones for 2024: Doubling Assessment Completion and Advancing Digital Medicine Innovation
17/09/2024
WEST PALM BEACH, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based [...]
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
17/09/2024
ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion expected by year end 2024 and commencement of dosing of ALS patients [...]

Pages